MCM
MGNX icon

MAI Capital Management’s MacroGenics MGNX Stock Holding History

MAI Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
+4,415
New +$9.42K ﹤0.01% 3033
2025
Q1 		– Sell
-140
Closed -$455 – 3520
2024
Q4 		$455 Buy
+140
New +$504 ﹤0.01% 3306

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

MAI Capital Management's MGNX Position: Q1 2026 in Review

MAI Capital Management opened a new position in MacroGenics (MGNX) in Q1 2026: 4,415 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #3033 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in MGNX as recently as Q4 2024.

MAI Capital Management first reported a position in MGNX in Q4 2024 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • MAI Capital Management held 4,415 shares of MacroGenics worth $12.8K as of Q1 2026.
  • MacroGenics was a new MAI Capital Management position in Q1 2026.
  • MacroGenics made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3033 holding.
  • MAI Capital Management first reported a position in MacroGenics in Q4 2024 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.